The GLP-1 Revolution: A Panacea for the Obesity Epidemic?
The potential of GLP-1 drugs to reshape global health and economic landscapes. 85+ Sources The global fight against obesity has reached a critical juncture with the advent of GLP-1 receptor agonist (GLP-1 RA) drugs. Medications such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the emerging retatrutide have demonstrated remarkable efficacy in promoting weight loss … Read more
